Sitting down with…Emily LeProust, CEO, Twist Bioscience

Products

Applications

Resources

COMPANY

Sitting down with…Emily LeProust, CEO, Twist Bioscience

Download the Article

DNA synthesis company Twist Bioscience has developed a revolutionary, silicon-based approach to building synthetic DNA. By miniaturising chemistry, and maximising synthesis throughout, it has ramped up the availability and accessibility of synthetic DNA for the biotech and biopharma industries. Lu Rahman chatted with Twist co-founder and CEO Emily LeProust about its path to success.

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Sitting down with…Emily LeProust, CEO, Twist Bioscience

Related Resources

Speeding up T-Cell Receptor Discovery for Adoptive Cell Therapy

Advanced DNA Tools for Engineering Better Chimeric Antigen Receptors

High-Throughput Platform to Develop Highly Potent & Functional Antibodies against G-protein Coupled Receptors